This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigations in testicular cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

NICE recommends that all patients with a swelling or mass in the body of the testis should be referred urgently for investigation (1).

These include:

  • scrotal ultrasound
    • investigation of choice
    • has a sensitivity of almost 100% in diagnosing testicular tumour
    • used to explore the contralateral testis (2)
    • urgent ultrasound should be carried out in men with
      • a scrotal mass that does not transilluminate
      • when the body of the testis cannot be palpated, such as when there is a reactive hydrocele (1)

  • tumour markers -
    • are prognostic factors used in diagnosis and staging (2)
    • includes -
      • serum beta human chorionic gonadotrophin (HCG)
      • lactate dehydrogenase (LDH) - measured specially in advanced disease
      • alpha-fetoprotein (AFP) *
    • lack of an increase does not exclude the disease

  • chest radiography for metastases

  • CT scan of the chest, abdomen and pelvis in order to stage the disease

  • testicular exploration and biopsy

* Note that elevated serum AFP levels indicate the presence of yolk sac elements, i.e. mixed germ cell tumours (especially embryonal carcinoma and yolk sac tumours).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.